{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:05Z","timestamp":1747181105627,"version":"3.40.5"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Kidney disease is a common complication of diabetes and the main cause of end-stage renal disease. Astragalus (Huangqi) injection in combination with angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers (ACEI\/ARBs) have been widely used for the treatment of diabetic kidney disease (DKD) in China. However, no supporting evidence yet exists with regard to the safety and effectiveness of this approach. Here a protocol is outlined for use in systematic evaluation of the safety and effectiveness of astragalus injection combined with ACEI\/ARB for the treatment of DKD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Randomised controlled trials will be retrieved from 8 scientific databases, including PubMed, Web of Science, EMBASE database, Cochrane Library, China National Knowledge Infrastructure, Wanfang, China Biomedical Literature CD-ROM Database and China Science Journal Database. Ongoing clinical trial databases will also be searched for studies published from the time of establishment of each database to September 1, 2022. that will include the Chinese Clinical Trial Registration Centre (www.chictr.org.cn\/), the World Health Organisation International Trial Registration Platform (https:\/\/www.who.int\/clinical-trials-registry-platform), Google Scholar (https:\/\/scholar.google.com\/), Baidu Scholar (https:\/\/xueshu.baidu.com), etc. The main outcome indicators included urinary albumin excretion rate or 24-hour urinary albumin excretion rate, and renal function (blood urea nitrogen, serum creatinine concentration). The secondary outcome indicators mainly include the following 4 aspects: blood sugar, blood pressure, blood lipid levels and adverse events. Two researchers will independently select and extract data from randomized controlled trials and determine risks of bias. Meta-analysis will be performed using Revman5.4 then the quality of evidence from randomized clinical trials will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) System tool.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This review will be the first to summarize meta-analysis results regarding the efficacy and safety of Huangqi injection combined with ACEI\/ARB when administered during any stage of diabetic nephropathy rather than during only a single stage of the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>It will provide high-quality guidance for the treatment of diabetic kidney disease and provide patients with more treatment options.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031490","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T21:30:26Z","timestamp":1673559026000},"page":"e31490","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy and safety of astragalus injection combined with ACEI\/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis"],"prefix":"10.1097","volume":"101","author":[{"given":"Zhiyue","family":"Zhu","sequence":"first","affiliation":[{"name":"College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjie","family":"Bao","sequence":"additional","affiliation":[{"name":"College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilin","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqun","family":"Song","sequence":"additional","affiliation":[{"name":"College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0616-7472","authenticated-orcid":false,"given":"Zheng","family":"Nan","sequence":"additional","affiliation":[{"name":"College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","article-title":"Trajectories of kidney function in diabetes: a clinicopathological update","volume":"17","author":"Oshima","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide epidemiology of diabetes-related end-stage renal disease, 2000-2015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"649587","DOI":"10.3389\/fphys.2021.649587","article-title":"Epigenetics and inflammation in diabetic nephropathy","volume":"12","author":"Shao","year":"2021","journal-title":"Front Physiol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4093\/dmj.2020.0217","article-title":"Treatment of diabetic kidney disease: current and future","volume":"45","author":"Yamazaki","year":"2021","journal-title":"Diabetes Metab J"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4062\/biomolther.2020.204","article-title":"Diabetic nephropathy\u2014a review of risk factors, progression, mechanism, and dietary management","volume":"29","author":"Natesan","year":"2021","journal-title":"Biomol Ther (Seoul)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","article-title":"AGE\/RAGE in diabetic kidney disease and ageing kidney","volume":"171","author":"Wu","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"154834","DOI":"10.1016\/j.metabol.2021.154834","article-title":"Exosomes: advances, development and potential therapeutic strategies in diabetic nephropathy","volume":"122","author":"Chen","year":"2021","journal-title":"Metabolism"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on diabetic nephropathy: core curriculum 2018","volume":"71","author":"Umanath","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000381757","article-title":"The prevalence and management of diabetic nephropathy in Asia","volume":"1","author":"Tomino","year":"2015","journal-title":"Kidney Dis (Basel)"},{"key":"R10-20250504","first-page":"2","volume":"10","author":"Agarwal","year":"2021","journal-title":"Pathogenesis of diabetic nephropathy"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3904\/kjim.2021.174","article-title":"The role of inflammation in diabetic kidney disease","volume":"36","author":"Jung","year":"2021","journal-title":"Korean J Intern Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e142243","DOI":"10.1172\/JCI142243","article-title":"Pharmacological treatment of hyperglycemia in type 2 diabetes","volume":"131","author":"Taylor","year":"2021","journal-title":"J Clin Invest"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.semnephrol.2021.03.003","article-title":"SGLT2 inhibitors and other novel therapeutics in the management of diabetic kidney disease","volume":"41","author":"Stanton","year":"2021","journal-title":"Semin Nephrol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14789450.2018.1545577","article-title":"Advances in understanding the role of angiotensin-regulated proteins in kidney diseases","volume":"16","author":"Sanz","year":"2019","journal-title":"Expert Rev Proteomics"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3390\/antiox10071143","article-title":"Metabolic changes and oxidative stress in diabetic kidney disease","volume":"10","author":"Sakashita","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"R16-20250504","first-page":"CD008369","article-title":"Astragalus (a traditional Chinese medicine) for treating chronic kidney disease","volume":"10","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12882-015-0031-7","article-title":"Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress","volume":"16","author":"Wang","year":"2015","journal-title":"BMC Nephrol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1080\/14656566.2020.1776262","article-title":"An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes\u2014an Asian perspective","volume":"21","author":"Saisho","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"3780572","DOI":"10.1155\/2017\/3780572","article-title":"Are the therapeutic effects of huangqi (astragalus membranaceus) on diabetic nephropathy correlated with its regulation of macrophage iNOS activity","volume":"2017","author":"Liao","year":"2017","journal-title":"J Immunol Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1839809","DOI":"10.1155\/2017\/1839809","article-title":"Mechanistic insight and management of diabetic nephropathy: recent progress and future perspective","volume":"2017","author":"Xue","year":"2017","journal-title":"J Diabetes Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1497449","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed Res Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:47:10Z","timestamp":1746334030000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":22,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031490","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}